MedTrace Logo

ERAS in Colorectal Surgery Diminishes the Negative Impact of Sarcopenia on Short Term Outcomes

NCT02618811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 171

Last updated 2015-12-01

No results posted yet for this study

Summary

So far, the impact of sarcopenia has been analysed only in patients undergoing traditional surgical procedures (laparotomy) or those with metastatic spread. As the ERAS protocol combined with minimally invasive access decreases postoperative metabolic disorders, it seems possible that it can limit the deleterious impact of sarcopenia as well. The aim of this study was to investigate whether the use of ERAS protocol in colorectal cancer patients influences the postoperative risk due to sarcopenia.

Conditions

Sponsors & Collaborators

  • Jagiellonian University

    lead OTHER

Principal Investigators

  • Michał Pędziwiatr, MD, PhD · 2nd Department of Surgery, Jagiellonian University, Krakow, Poland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-10-31
Completion
2015-11-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02618811 on ClinicalTrials.gov